Comparison of Two Molecular Methods for Rapid Diagnosis of Tuberculosis

Jau Ching Lee, Cheng-Hui Wang, Yi-Lin Liang, Sung-tzu Tsao, Chi-Chih Liao, Fang-Lan Yu, Ching-Sheng Hung, Yi-Yuan Yang, Giueng-Chueng Wang

Research output: Contribution to journalArticle

Abstract

Tuberculosis remains a global prevalent infectious disease and a serious public-health problem in Taiwan. This study was purposed to evaluate the performance of identifying Mycobacterium tuberculosis complex (MTBC) by following two methods: Roche COBAS TaqMan MTB Test (COBAS assay) which is a real-time PCR-based kit, and MP FASTSURE TB DNA Rapid Test (MP assay) which uses the cross-priming amplification technology for the qualitative detection of MTBC DNA. We collect 210 clinical samples to assess the performance of these two methods between January and December 2011. The results obtained were compared with those from conventional methods. The sensitivity, specificity, and positive/negative predictive values (PPV/NPV) of MP assay for 144 routine clinical specimens were 92.75%, 98.67%, 98.46%, and 93.67%, respectively; and those were 91.30%, 89.33%, 100%, 93.06% for COBAS assay. The sensitivity, specificity, PPV and NPV of MP assay for 50 positive BACTEC MGIT 960 cultures give satisfying outcomes (100%, 100%, 100% and 100%, respectively) ; and those were 100%, 52.94%, 100%, 100% for COBAS assay. Furthermore, the sensitivity, specificity, PPV and NPV of MP assay for 16 positive Löwenstein-Jensen cultures give satisfying outcomes (100%, 100%, 100% and 100%, respectively) ; and those were 50%, 16.67%, 100%, 100% for COBAS assay. Finally, the sensitivity and specificity of MP assay for total 210 samples were 95.28% and 99.04%, respectively; and those were 92.45%, 75% for COBAS assay. Nevertheless, results also indicate that both working time and cost required for MP assay were more effective than COBAS assay. MP assay could be considered as an alternative to currently available identification methods.
Original languageEnglish
Pages (from-to)14-23
Number of pages10
JournalJournal of Biomedical & Laboratory Sciences
Volume30
Issue number1
Publication statusPublished - 2018

Fingerprint

Tuberculosis
Sensitivity and Specificity
Mycobacterium tuberculosis
Cross-Priming
DNA
Taiwan
Communicable Diseases
Real-Time Polymerase Chain Reaction
Public Health
Technology
Costs and Cost Analysis

Keywords

  • Cross-Priming amplification
  • real time-PCR
  • Tuberculosis
  • 結核病

Cite this

Comparison of Two Molecular Methods for Rapid Diagnosis of Tuberculosis. / Lee, Jau Ching; Wang, Cheng-Hui; Liang, Yi-Lin; Tsao, Sung-tzu; Liao, Chi-Chih; Yu, Fang-Lan; Hung, Ching-Sheng; Yang, Yi-Yuan; Wang, Giueng-Chueng.

In: Journal of Biomedical & Laboratory Sciences, Vol. 30, No. 1, 2018, p. 14-23.

Research output: Contribution to journalArticle

Lee, Jau Ching ; Wang, Cheng-Hui ; Liang, Yi-Lin ; Tsao, Sung-tzu ; Liao, Chi-Chih ; Yu, Fang-Lan ; Hung, Ching-Sheng ; Yang, Yi-Yuan ; Wang, Giueng-Chueng. / Comparison of Two Molecular Methods for Rapid Diagnosis of Tuberculosis. In: Journal of Biomedical & Laboratory Sciences. 2018 ; Vol. 30, No. 1. pp. 14-23.
@article{77651ad8a7434405a89661b0c4abd9ae,
title = "Comparison of Two Molecular Methods for Rapid Diagnosis of Tuberculosis",
abstract = "Tuberculosis remains a global prevalent infectious disease and a serious public-health problem in Taiwan. This study was purposed to evaluate the performance of identifying Mycobacterium tuberculosis complex (MTBC) by following two methods: Roche COBAS TaqMan MTB Test (COBAS assay) which is a real-time PCR-based kit, and MP FASTSURE TB DNA Rapid Test (MP assay) which uses the cross-priming amplification technology for the qualitative detection of MTBC DNA. We collect 210 clinical samples to assess the performance of these two methods between January and December 2011. The results obtained were compared with those from conventional methods. The sensitivity, specificity, and positive/negative predictive values (PPV/NPV) of MP assay for 144 routine clinical specimens were 92.75{\%}, 98.67{\%}, 98.46{\%}, and 93.67{\%}, respectively; and those were 91.30{\%}, 89.33{\%}, 100{\%}, 93.06{\%} for COBAS assay. The sensitivity, specificity, PPV and NPV of MP assay for 50 positive BACTEC MGIT 960 cultures give satisfying outcomes (100{\%}, 100{\%}, 100{\%} and 100{\%}, respectively) ; and those were 100{\%}, 52.94{\%}, 100{\%}, 100{\%} for COBAS assay. Furthermore, the sensitivity, specificity, PPV and NPV of MP assay for 16 positive L{\"o}wenstein-Jensen cultures give satisfying outcomes (100{\%}, 100{\%}, 100{\%} and 100{\%}, respectively) ; and those were 50{\%}, 16.67{\%}, 100{\%}, 100{\%} for COBAS assay. Finally, the sensitivity and specificity of MP assay for total 210 samples were 95.28{\%} and 99.04{\%}, respectively; and those were 92.45{\%}, 75{\%} for COBAS assay. Nevertheless, results also indicate that both working time and cost required for MP assay were more effective than COBAS assay. MP assay could be considered as an alternative to currently available identification methods.",
keywords = "Cross-Priming amplification, real time-PCR, Tuberculosis, 結核病",
author = "Lee, {Jau Ching} and Cheng-Hui Wang and Yi-Lin Liang and Sung-tzu Tsao and Chi-Chih Liao and Fang-Lan Yu and Ching-Sheng Hung and Yi-Yuan Yang and Giueng-Chueng Wang",
year = "2018",
language = "English",
volume = "30",
pages = "14--23",
journal = "Journal of Biomedical & Laboratory Sciences",
issn = "1013-7653",
publisher = "社團法人台灣醫事檢驗學會",
number = "1",

}

TY - JOUR

T1 - Comparison of Two Molecular Methods for Rapid Diagnosis of Tuberculosis

AU - Lee, Jau Ching

AU - Wang, Cheng-Hui

AU - Liang, Yi-Lin

AU - Tsao, Sung-tzu

AU - Liao, Chi-Chih

AU - Yu, Fang-Lan

AU - Hung, Ching-Sheng

AU - Yang, Yi-Yuan

AU - Wang, Giueng-Chueng

PY - 2018

Y1 - 2018

N2 - Tuberculosis remains a global prevalent infectious disease and a serious public-health problem in Taiwan. This study was purposed to evaluate the performance of identifying Mycobacterium tuberculosis complex (MTBC) by following two methods: Roche COBAS TaqMan MTB Test (COBAS assay) which is a real-time PCR-based kit, and MP FASTSURE TB DNA Rapid Test (MP assay) which uses the cross-priming amplification technology for the qualitative detection of MTBC DNA. We collect 210 clinical samples to assess the performance of these two methods between January and December 2011. The results obtained were compared with those from conventional methods. The sensitivity, specificity, and positive/negative predictive values (PPV/NPV) of MP assay for 144 routine clinical specimens were 92.75%, 98.67%, 98.46%, and 93.67%, respectively; and those were 91.30%, 89.33%, 100%, 93.06% for COBAS assay. The sensitivity, specificity, PPV and NPV of MP assay for 50 positive BACTEC MGIT 960 cultures give satisfying outcomes (100%, 100%, 100% and 100%, respectively) ; and those were 100%, 52.94%, 100%, 100% for COBAS assay. Furthermore, the sensitivity, specificity, PPV and NPV of MP assay for 16 positive Löwenstein-Jensen cultures give satisfying outcomes (100%, 100%, 100% and 100%, respectively) ; and those were 50%, 16.67%, 100%, 100% for COBAS assay. Finally, the sensitivity and specificity of MP assay for total 210 samples were 95.28% and 99.04%, respectively; and those were 92.45%, 75% for COBAS assay. Nevertheless, results also indicate that both working time and cost required for MP assay were more effective than COBAS assay. MP assay could be considered as an alternative to currently available identification methods.

AB - Tuberculosis remains a global prevalent infectious disease and a serious public-health problem in Taiwan. This study was purposed to evaluate the performance of identifying Mycobacterium tuberculosis complex (MTBC) by following two methods: Roche COBAS TaqMan MTB Test (COBAS assay) which is a real-time PCR-based kit, and MP FASTSURE TB DNA Rapid Test (MP assay) which uses the cross-priming amplification technology for the qualitative detection of MTBC DNA. We collect 210 clinical samples to assess the performance of these two methods between January and December 2011. The results obtained were compared with those from conventional methods. The sensitivity, specificity, and positive/negative predictive values (PPV/NPV) of MP assay for 144 routine clinical specimens were 92.75%, 98.67%, 98.46%, and 93.67%, respectively; and those were 91.30%, 89.33%, 100%, 93.06% for COBAS assay. The sensitivity, specificity, PPV and NPV of MP assay for 50 positive BACTEC MGIT 960 cultures give satisfying outcomes (100%, 100%, 100% and 100%, respectively) ; and those were 100%, 52.94%, 100%, 100% for COBAS assay. Furthermore, the sensitivity, specificity, PPV and NPV of MP assay for 16 positive Löwenstein-Jensen cultures give satisfying outcomes (100%, 100%, 100% and 100%, respectively) ; and those were 50%, 16.67%, 100%, 100% for COBAS assay. Finally, the sensitivity and specificity of MP assay for total 210 samples were 95.28% and 99.04%, respectively; and those were 92.45%, 75% for COBAS assay. Nevertheless, results also indicate that both working time and cost required for MP assay were more effective than COBAS assay. MP assay could be considered as an alternative to currently available identification methods.

KW - Cross-Priming amplification

KW - real time-PCR

KW - Tuberculosis

KW - 結核病

M3 - Article

VL - 30

SP - 14

EP - 23

JO - Journal of Biomedical & Laboratory Sciences

JF - Journal of Biomedical & Laboratory Sciences

SN - 1013-7653

IS - 1

ER -